Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 691-695, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.691-695.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Rapid Detection of Mutations in the 23S rRNA
Gene of Helicobacter pylori That Confers Resistance
to Clarithromycin Treatment to the Bacterium
Masayuki
Matsumura,1,*
Yoko
Hikiba,1
Keiji
Ogura,1,2
Goichi
Togo,2
Izumi
Tsukuda,1
Kenji
Ushikawa,1
Yasushi
Shiratori,2 and
Masao
Omata2
The Institute for Adult Diseases, Asahi Life
Foundation, 1-9-14 Nishi-Shinjuku, Shinjuku-ku, Tokyo
160-0023,1 and Division of
Gastroenterology, Department of Internal Medicine, Faculty of
Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo,
113-8655,2 Japan
Received Recieved 17 July 2000/Returned for modification 20 September
2000/Accepted 11 November 2000
 |
ABSTRACT |
We developed a new method capable of detecting point mutations in
the 23S rRNA gene of Helicobacter pylori using a
LightCycler. Our method can detect a mutation in this gene in less than
1 h and can process many samples at once, thereby contributing to the selection of patients suitable for clarithromycin-based therapy.
 |
INTRODUCTION |
The resistance of Helicobacter
pylori to clarithromycin is a major cause of failure in
eradication therapies (8); furthermore, mutations in the
23S rRNA gene (an A-to-G transition at nucleotide position 2143 [A2143G] or 2144 [A2144G]) have been found to confer resistance to
clarithromycin to H. pylori (3, 8, 10, 12). Reports indicate that the rate of eradication of H. pylori
with clarithromycin treatment is only 40% for mutant strains, whereas it is 85% for wild-type strains (6).
To date, the detection of mutations in the H. pylori 23S
rRNA gene is mainly performed by PCR, followed by digestion with restriction enzymes. The resulting DNA fragments are separated on
agarose or acrylamide gels, and the presence of a mutation is
determined by the pattern of the restriction fragment length polymorphism (RFLP) by PCR-RFLP analysis (6, 7). This
detection procedure is, however, time-consuming and requires
optimization of the PCR. In addition, contamination of the amplified
product can also cause false-positive results. Recently, a new
high-speed thermal cycler that uses glass capillaries (LightCycler;
Roche Diagnostics, Tokyo, Japan) has been introduced. Using this
recently introduced machine along with attached fluorescenct probes, we have established a new method that detects point mutations in the 23S
rRNA gene of H. pylori. We further examined the sensitivity and specificity of this method by comparison with PCR-RFLP analysis as
a "gold standard" and analysis of clinical samples (gastric tissue)
for the presence of mutant H. pylori strains.
 |
MATERIALS AND METHODS |
Gastric tissues.
Gastric tissue was taken from 186 patients
with epigastralgia during gastric endoscopy examination, and a rapid
urease test was performed with a Helicocheck kit (Otsuka
Pharmaceutical, Tokyo, Japan). DNA was isolated from each tissue with a
QIAamp DNA mini kit (Qiagen, Tokyo, Japan) according to the
manufacturer's protocol. The isolated DNA was then dissolved in 20 µl of 1× TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 8.0]) and stored
at
20°C until use.
By using specimens obtained from the antrums of another 84 patients who
were Helicocheck test positive, H. pylori was isolated and
cultured on Columbia agar with 5% (vol/vol) horse blood and Dent
antibiotic supplement (Oxford, Basingstoke, United Kingdom) at 37°C
for 5 days under microaerobic conditions by using the Campy-Pak system
(BBL, Cockeysville, Md.). Identification of H. pylori was
based on colony morphology, microscopy, and positive urease, catalase,
and oxidase activities. The MIC of clarithromycin was determined by the
agar dilution method with agar plates containing clarithromycin at
concentrations ranging from 0.03 to 100 mg/liter. The MIC was defined
as the minimum concentration of clarithromycin at which bacterial
growth was inhibited. H. pylori strains were classified as
resistant to clarithromycin when the MIC was >1 mg/liter.
Amplification and melting analysis of 23S rRNA gene of H. pylori using the LightCycler.
The primers used for PCR of
the 23S rRNA gene of H. pylori (GenBank accession no.
U27270) were CRFL-1 (5'-ATGAATGGCGTAACGAGAT-3'; nucleotides
2051 to 2070) and CRRL-2 (5'-ACACTCAACTTGCGATTCC-3'; nucleotides 2410 to 2391), and the result was a 360-bp product (Fig. 1). In addition, two kinds of
probes (detection probe MP-W and anchor probe AP-2186) were included in
the PCR mixture. The detection probe was 5' labeled with LC-Red 640 and
3' phosphorylated, and the anchor probe was 3' labeled with fluorescein
isothiocyanate. The latter was located downstream of the former at a
distance of 1 nucleotide. The locations of these primers and probes are shown in Fig. 1.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
Locations of primers and hybridization probes used for
our method. Primers used are shown in italics at each 5' end (primer
CRFL-1; nucleotides 2051 to 2070) and 3' end (primer CRRL-2;
nucleotides 2410 to 2391). The amplified product is 360 bp. Both
detection (MP-W) and anchor (AP-2186) probes are shown midproduct. MP-W
is 3' phosphorylated and 5' labeled with LC-Red 640, and AP-2186 is
labeled with fluorescein isothiocyanate at its 3' end. Other kinds of
detection probes are also shown in the lower part of the figure.
|
|
With a LightCycler, PCR was performed in 20-µl volumes in glass
capillaries (Roche Diagnostics). Twenty microliters of PCR mixture
contained 2 µl of sample DNA, 13.2 µl of H2O, 1.6 µl
of MgCl2 (25 mM), 0.4 µl each of CRFL-1 and CRRL-2 (25 mM
each), 0.2 ml each of MP-W (40 mM) and AP-2151 (20 mM), and 2 µl of
DNA-Master Hybridization Probes (Roche Diagnostics) containing
Taq DNA polymerase, reaction buffer, a deoxynucleoside
triphosphate mixture, and 10 mM MgCl2 in a 10×
concentrate. Cycling conditions consisted of an initial denaturation at
94°C for 2 min, followed by 45 cycles with denaturation at 94°C for
0 s, annealing at 55°C for 10 s, and extension at 72°C
for 15 s, with a ramping time of 20°C/s.
After completion of the amplification process, samples of the reaction
mixture were denatured at 94°C for 0 s, held at 50°C for
5 s, and then slowly heated to 80°C at a ramp rate of 0.1°C/s. During this process, declining fluorescence was continuously monitored, and melting curves were constructed automatically with software attached to the LightCycler. Melting curves were converted to melting
peaks by plotting the negative derivative of the fluorescence with
respect to temperature (
dF/dT) (see Fig. 2).
Standard DNA.
Standard DNAs were synthesized in vitro by PCR
(with primers CRFL-1 and CRR1-2) with DNAs from wild-type strains and
strains with the A2143G and A2144G mutations as templates. The
sequences of these standard DNAs were in complete accordance with those reported for the 23S rRNA gene of H. pylori in GenBank
(accession number U27270). These DNAs were used for each experiment.
Melting analysis using DNA standards.
With each standard DNA
(DNAs of the wild type and the strains with the A2143G and A2144G
mutations), a melting analysis was done with wild-type-specific
detection probes (MP-W) as well as A2143G or A2144G mutation-specific
detection probes (MP-2143 and MP-2144, respectively) (see Fig. 2).
Sensitivity in detecting mutant strains either by RFLP analysis
or with the Light Cycler.
In order to clarify the sensitivity of
detection of mutant H. pylori among wild-type strains mutant
DNA (from strains with either the A2143G or the A2144G mutations),
synthesized as described above, was mixed with the DNA of the wild-type
strain at ratios of 1:1, 1:1/2, 1:1/10, 1:1/20, and 1:1/50. These
mixtures were processed for melting analysis with the LightCycler.
PCR-RFLP analysis.
PCR-RFLP analysis was performed as
described by Maeda et al. (6) with primers CRF-4
(5'-AGT GGA GGT GAA AATTCC-3'; nucleotides 2105 to 2122) and
CRR-1 (5'-TAA GAG CCA AAG CCC TTA C-3'; nucleotides 2239 to 2221), resulting in a 135-bp product. PCR was performed in a
thermal cycler (GeneAmp PCR system 9600; Applied Biosystems) with a
50-µl volume containing 2 µl of sample DNA, 5 µl of 10× PCR
buffer (500 mM KCl, 100 mM Tris-HCl [pH 8.3], 15 mM
MgCl2, 0.01% [wt/vol] gelatin), 0.5 µl each of CRF-4
and CRR-1 at 25 mM, 0.4 µL of a 25 mM deoxynucleoside triphosphate
mixture, and 1 U of Taq DNA polymerase (Applied Biosystems).
After heating of the mixture at 94°C for 5 min, PCR was performed for
34 cycles, with denaturation at 94°C for 30 s and extension at
57°C for 30 s, followed by incubation at 72°C for 4 min. The
PCR product was digested with either the BsaI or the
MboII restriction enzyme and was then electrophoresed on an
acrylamide gel. The presence of the mutant was detected by examination
of the patterns of the restricted fragments. While PCR products derived
from the mutant were digested with either BsaI (mutant with
the A2144G mutation) or MboII (mutant with the A2143G
mutation), this was not possible for the wild-type strain.
 |
RESULTS |
Melting analysis of wild-type strain and two kinds of mutants with
mutations in the 23S rRNA gene.
By using standard DNAs, including
those of the wild type and mutants with the A2143G and A2144G
mutations, a melting analysis was performed. By using M-WP, the
fluorescence emitted by the mutant strains declined more rapidly than
that emitted by the wild-type strain. Figure
2 shows the melting peaks of each
standard DNA, with distinct peaks at different temperatures. In
addition, by using MP-2144 or MP-2143 as the detection probe, the
presence of each mutant strain could be clarified (Fig. 2).

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Melting analysis was performed with templates (DNAs from
the wild type and mutants with the A2144G and A2143G mutations)
synthesized in vitro. Melting curves were converted to melting peaks by
plotting the negative derivative of the fluorescence
( dF/dT) with respect to temperature. The melting peak for
each strain is shown at a different temperature. In addition to the
MP-W probe, two other probes (each specific to the mutant with either
the A2144G or the A2143G mutation) were used. The probes used are shown
above each graph. The melting peaks for each strain (wild type, yellow;
mutant with the A2144G mutation, pink; mutant with the A2143G mutation,
green) are shown in the same figure. The vertical lines in each graph
represent the melting temperatures of each template.
|
|
Detection of mutants among wild-type H. pylori.
As
shown in Fig. 3, the mutant with the
A2143G mutation, as well as the mutant with the A2144G mutation (data
not shown), could be detected when it contaminated a mixture with the
wild type at a level of as little as 10%.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Using a mixture of standard DNAs (from the wild type and
the mutant with the A2144G mutation), the sensitivity of detection of a
mutant among wild-type H. pylori strains was examined. The
template for the mutant with the A2144G mutation was mixed with the
template for the wild type at ratios (wild type to mutant) of 1:1,
1:1/2, 1:1/5, 1:1/10, 1:1/20, and 1:1/50. Both wild type-only and
mutant-only templates were included as controls. The detection probe
used was MP-W. As the ratio of the mutant DNA as a contaminant of the
wild-type DNA increased, another peak appeared at a temperature in
accordance with the melting temperature of the mutant DNA. These peaks
can be recognized until the ratio becomes as low as 1:1/10.
|
|
MIC for H. pylori and detection of mutants by melting
analysis.
Table 1 shows the
correlation between the genotypes of the H. pylori strains
and the MIC of clarithromycin. All mutant H. pylori isolates
were resistant to clarithromycin.
Detection of H. pylori mutants by PCR-RFLP analysis and
melting analysis.
Of 186 patients, H. pylori was
detected in 151 patients with the Helicocheck kit. The 23S rRNA gene of
H. pylori was amplified from all 151 Helicocheck-positive
patients but not the 35 Helicocheck-negative patients.
If the existence of a mutant was suspected, the melting analysis was
repeated with mutant-specific detection probes (MP-2143 or MP-2144),
for clarification of the mutant type (Fig. 2). Using a combination of
three kinds of probes, we examined strains for the presence of the
mutant 23S rRNA gene. One hundred nineteen patients had wild-type
strains only, 19 patients had mutant strains only, and 13 patients had
both wild-type and mutant strains (Table 2). These results were in accordance with
the results obtained by PCR-RFLP analysis.
 |
DISCUSSION |
For the LightCyler melting analysis, we used a long anchor probe
(a 36-mer) along with a second shorter probe (an 18-mer) for the
purpose of recognizing adjacent sequences with the shorter probe lying
over the mutation site. When these probes hybridize with the PCR
product within a 1-nucleotide interval, fluorescence is emitted by
fluorescence resonance energy transfer (4). After completion of the PCR, the temperature was slowly raised from 50 to
80°C. Due to the great stability of the anchor probe, a loss of
fluorescence occurs as the shorter probe melts off the template.
Meanwhile, the wild-type-specific detection probe dissociates from the
mutant-specific detection probe at a temperature lower than that for
the wild-type sequence. A single-base mismatch under the detection
probe results in a shift in the melting temperature to a lower
temperature (1). This shift leads to another peak at a
temperature lower than that for the wild-type strain (Fig. 2). By
changing the kinds of detection probes, we can determine the presence
of mutants with the A2143G and A2144G mutations.
The A2143C mutation, recently reported by Stone et al. (9)
and Occhialini et al. (8), was not searched for in the
present study because Matsuoka et al. (7) and Maeda et al.
(5) reported that the mutation was not detected in either
82 or 412 strains, respectively, isolated from gastric tissue derived
from Japanese patients. However, by using a detection probe which is
hybridized with the strain with the A2143C mutation, the mutation could
be detected by our method. We are preparing the probe and examining whether the mutation was detected among strains from Japanese patients.
As shown in Fig. 3, LightCycler melting analysis can detect mutants
when they are present among wild-type strains at a level of as little
as 10%. In addition, the ratio of contaminant mutants among wild-type
strains can be estimated by comparing the melting curves with those
obtained by using a mixture of standard DNAs (Fig. 3).
The sensitivity of detection of the mutant between PCR-RFLP analysis
and LightCycler melting analysis was compared with 186 gastric tissue
specimens. The results obtained by either method were comparable for
all specimens. Our method could be as useful as PCR-RFLP analysis.
By using a LightCycler, the whole process was completed within 40 min.
Due to the quick adaptation of temperature in the glass capillary (high
surface-to-volume ratio), PCR can occur under quicker cycling
conditions. Moreover, different from the PCR-RFLP technique, we need
not deal with the amplified product once the reaction mixture is set in
the LightCycler. Therefore, this simple procedure results in less
chance of contamination and eliminates the need to perform a digestion
with restriction enzymes.
As shown at Table 1, mutant H. pylori isolates were all
resistant to clarithromycin. Therefore, our method could predict the
presence of a clarithromycin-resistant strain before cultural data for
H. pylori are obtained.
The coexistence of wild-type and mutant strains of H. pylori
has been reported in several papers (2, 7, 11, 13, 14).
Also, reportedly, clarithromycin-resistant and clarithromycin-sensitive strains do coexist in the same patient (13, 14), even
among patients with no history of clarithromycin exposure
(7). On the other hand, it has been observed that
failed therapy with clarithromycin-based regimens may cause
antimicrobial resistance in H. pylori (2, 11).
Although the mechanism through which the clarithromycin-resistant
strain appears during treatment remains to be clarified, our method may
help to further elucidate this mechanism. In addition, the possibility
of the existence of a heterozygous strain, with only one of two 23S
rRNA genes containing a base substitution, could not be denied.
In conclusion, our method can easily detect the presence of a
clarithromycin-resistant strain and can also process many samples at
once, thereby contributing to the identification of those patients suitable for clarithromycin-based therapy for the treatment of H. pylori infection.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: The Institute
for Adult Diseases, Asahi Life Foundation, 1-9-14 Nishi-Shinjuku,
Shinjuku-ku, Tokyo 160-0023, Japan. Phone: 81-3-3343-2151. Fax:
81-3-3344-6275. E-mail: m-matsumura{at}asahi-life.or.jp.
 |
REFERENCES |
| 1.
|
Aslanidis, C.,
M. Nauck, and G. Schmitz.
1999.
High-speed prothrombin G-A 20210 and methylenetetrahydrofolate reductase C-T 677 mutation detection using real-time fluorescence PCR and melting curves.
BioTechniques
27:234-238[Medline].
|
| 2.
|
Enroth, H.,
B. Bjorkholm, and L. Engstrand.
1999.
Occurrence of resistance mutation and clonal expansion in Helicobacter pylori multiple-strain infection: a potential risk in clarithromycin-based therapy.
Clin. Infect. Dis.
28:1305-1307[Medline].
|
| 3.
|
Hulten, K.,
A. Gibreel, and L. Engstrand.
1997.
Macrolide resistance in Helicobacter pylori: mechanism and stability in strains from clarithromycin-treated patients.
Antimicrob. Agents Chemother.
41:2550-2553[Abstract].
|
| 4.
|
Livak, K. J.,
S. J. A. Flood,
J. Marmaro,
W. Giusti, and K. Deetz.
1995.
Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.
PCR Methods Appl.
4:357-362[Medline].
|
| 5.
|
Maeda, S.,
H. Yoshida,
H. Matsunaga,
K. Ogura,
O. Kawamata,
Y. Shiratori, and M. Omata.
2000.
Detection of clarithromycin-resistant Helicobacter pyroli strains by a preferential homoduplex formation assay.
J. Clin. Microbiol.
38:210-214[Abstract/Free Full Text].
|
| 6.
|
Maeda, S.,
H. Yoshida,
K. Ogura,
F. Kanai,
Y. Shiratori, and M. Omata.
1998.
Helicobacter pyroli specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance.
Gut
43:317-321[Abstract/Free Full Text].
|
| 7.
|
Matsuoka, M.,
Y. Yoshida,
K. Hayakawa,
S. Fukuchi, and K. Sugano.
1999.
Similtaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.
Gut
45:503-507[Abstract/Free Full Text].
|
| 8.
|
Occhialini, A.,
M. Urdaci,
F. Doucet-Populaire,
C. M. Bebear,
H. Lamouliatte, and F. Megraud.
1997.
Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.
Antimicrob. Agents Chemother.
41:2724-2728[Abstract].
|
| 9.
|
Stone, G. G.,
D. Shortridge,
R. K. Flamm,
J. Versalovic,
J. Beyer,
K. Idler,
L. Zulawinski, and S. K. Tanaka.
1996.
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori.
Helicobacter
1:227-228[Medline].
|
| 10.
|
Talor, N. S.,
J. G. Fox,
N. S. Akopyrants,
D. E. Berg,
N. Thompson,
B. Shames,
L. Yan,
E. Fontham,
F. Janney,
F. M. Hunter, and P. Correa.
1995.
Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.
J. Clin. Microbiol.
33:918-923[Abstract].
|
| 11.
|
Vakil, N.,
B. Hahn, and D. McSorley.
1998.
Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States.
Am. J. Gastroenterol.
93:1432-1435[CrossRef][Medline].
|
| 12.
|
Versalovic, J.,
D. Shortridge,
K. Kibler,
M. V. Griffy,
J. Beyer,
R. K. Flamm,
S. K. Tanaka,
D. Y. Graham, and M. F. Go.
1996.
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.
Antimicrob. Agents Chemother.
40:477-480[Abstract].
|
| 13.
|
Wang, G. E.,
Q. Jiang, and D. E. Taylor.
1998.
Genotypic characterization of clarithromycin-resistant and -susceptible Helicobacter pylori strains from the same patient demonstrates existence of two unrelated isolates.
J. Clin. Microbiol.
36:2730-2731[Abstract/Free Full Text].
|
| 14.
|
Wang, G. E.,
M. S. Rahman,
M. Z. Humayun, and D. E. Taylor.
1999.
Multiplex sequence analysis demonstrates the competitive growth advantage of the A-to-G mutants of clarithromycin-resistant Helicobacter pylori.
Antimicrob. Agents Chemother.
43:683-685[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, February 2001, p. 691-695, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.691-695.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Burucoa, C., Garnier, M., Silvain, C., Fauchere, J.-L.
(2008). Quadruplex Real-Time PCR Assay Using Allele-Specific Scorpion Primers for Detection of Mutations Conferring Clarithromycin Resistance to Helicobacter pylori. J. Clin. Microbiol.
46: 2320-2326
[Abstract]
[Full Text]
-
Megraud, F., Lehours, P.
(2007). Helicobacter pylori Detection and Antimicrobial Susceptibility Testing. Clin. Microbiol. Rev.
20: 280-322
[Abstract]
[Full Text]
-
Glocker, E., Berning, M., Gerrits, M. M., Kusters, J. G., Kist, M.
(2005). Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori. Antimicrob. Agents Chemother.
49: 3166-3170
[Abstract]
[Full Text]
-
Schabereiter-Gurtner, C., Hirschl, A. M., Dragosics, B., Hufnagl, P., Puz, S., Kovach, Z., Rotter, M., Makristathis, A.
(2004). Novel Real-Time PCR Assay for Detection of Helicobacter pylori Infection and Simultaneous Clarithromycin Susceptibility Testing of Stool and Biopsy Specimens. J. Clin. Microbiol.
42: 4512-4518
[Abstract]
[Full Text]
-
Megraud, F
(2004). H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut
53: 1374-1384
[Full Text]
-
Chisholm, S. A., Owen, R. J.
(2004). Frameshift mutations in frxA occur frequently and do not provide a reliable marker for metronidazole resistance in UK isolates of Helicobacter pylori. J Med Microbiol
53: 135-140
[Abstract]
[Full Text]
-
Lascols, C., Lamarque, D., Costa, J.-M., Copie-Bergman, C., Le Glaunec, J.-M., Deforges, L., Soussy, C.-J., Petit, J.-C., Delchier, J.-C., Tankovic, J.
(2003). Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H. pylori Isolates from Gastric Biopsy Specimens by Real-Time PCR. J. Clin. Microbiol.
41: 4573-4577
[Abstract]
[Full Text]
-
Oleastro, M., Menard, A., Santos, A., Lamouliatte, H., Monteiro, L., Barthelemy, P., Megraud, F.
(2003). Real-Time PCR Assay for Rapid and Accurate Detection of Point Mutations Conferring Resistance to Clarithromycin in Helicobacter pylori. J. Clin. Microbiol.
41: 397-402
[Abstract]
[Full Text]
-
Miller, N., Cleary, T., Kraus, G., Young, A. K., Spruill, G., Hnatyszyn, H. J.
(2002). Rapid and Specific Detection of Mycobacterium tuberculosis from Acid-Fast Bacillus Smear-Positive Respiratory Specimens and BacT/ALERT MP Culture Bottles by Using Fluorogenic Probes and Real-Time PCR. J. Clin. Microbiol.
40: 4143-4147
[Abstract]
[Full Text]
-
Menard, A., Santos, A., Megraud, F., Oleastro, M.
(2002). PCR-Restriction Fragment Length Polymorphism Can Also Detect Point Mutation A2142C in the 23S rRNA Gene, Associated with Helicobacter pylori Resistance to Clarithromycin. Antimicrob. Agents Chemother.
46: 1156-1157
[Full Text]
-
Russmann, H., Adler, K., Haas, R., Gebert, B., Koletzko, S., Heesemann, J.
(2001). Rapid and Accurate Determination of Genotypic Clarithromycin Resistance in Cultured Helicobacter pylori by Fluorescent In Situ Hybridization. J. Clin. Microbiol.
39: 4142-4144
[Abstract]
[Full Text]